Oncotarget New Insights into HER2-Mutated Non-Small Cell Lung Cancer in Brazil In non–small cell lung cancer (NSCLC), alterations in the HER2 (ERBB2) gene define a... read more October 8, 2025
Oncotarget Amivantamab Monotherapy in Rare EGFR-Mutated Advanced NSCLC Amivantamab, an anti-EGFR/MET bispecific antibody, shows efficacy in EGFR-mutated NSCLC, but its role in... read more August 26, 2025
Oncotarget A Rare Genetic Shift That Helped Lung Cancer Evade Treatment This case adds to the literature on bypass signaling as a mechanism of resistance to... read more March 12, 2025
Oncotarget Trending With Impact: Unconventional Method Effectively Targets NSCLC In a trending paper published by Oncotarget, researchers developed a divergent strategy to treat non-small... read more September 30, 2021
Oncotarget Trending with Impact: Machine Learning Used to Compare ALK Inhibitors Researchers use a computer simulated modeling system to highlight the strengths and weaknesses of two... read more March 4, 2021
Oncotarget Trending with Impact: Novel MicroRNA Underexpressed in Lung Cancer In search of new ways to target lung cancer cells, researchers in this study demonstrated... read more February 4, 2021